RondelO IV-set: Standardized IV therapy for Medevac according to 10-1-2 care chain
| Reference number | |
| Coordinator | CYTO365 AB |
| Funding from Vinnova | SEK 1 000 000 |
| Project duration | November 2025 - August 2026 |
| Status | Ongoing |
| Venture | Civil-military synergies |
| Call | Acceleration of civil-military innovations by 2025 |
Purpose and goal
The project aims to field-verify the RondelO IV-set in military evacuation to give support to 10-1-2 principle. Verification to take place in realistic operational environments, Black Hawk, Rib boat and Ambulances with confined space and vibration, to explore adaption of Intravenous Infusion and usage of dose banding to increase shelf life of medicine for field hospitals without need of hospital pharmacy preparation. Test protocols and verification will be performed together with military.
Expected effects and result
The RondelO IV-set may replace existing fragile stopcock chains and bulky manifolds with a compact, sealed unit where only one drug flows at a time and a neutral flush ensures safety. This safety-by-design avoids drug mixing and enables error-proof handling even in vibration, darkness, or stressful environments. RondelO IV-set may also be used together with dose banding without the need of pharmacy preparation. From NATO’s perspective it´s relevant to Biotechnology and Human Enhancement.
Planned approach and implementation
The Project is divided into Work Packages. Package 1 to clarify both the technical and market-related conditions for RondelO in dual-use applications. Package 2 development and plan of study protocols for defense-relevant environments with potential adaptions to be used in helicopters, ambulances, RIB boats, and field hospitals. Package 3 verification of RondelO IV-set under realistic military conditions. Package 4 Prepares RondelO IV-set for long-term integration into military supply chains.